|
Dear VIJAY PITHADIA:
Your April 2013 digital issue of P&T journal is available.
This issue contains:
Feature articles
- Formulary Evaluation Using a Class Review Approach
Experience and Results From an Academic Medical Center
One institution's review of 17 drug classes led to 3 formulary additions, 15 deletions, 5 new therapeutic interchanges, and 6 drug-safety issues requiring action. Cost-savings opportunities also resulted from using generic medications and alternative product formulations. - Presentation and Management of Herpes Zoster (Shingles) in the Geriatric Population
Current treatment of herpes zoster includes antiviral agents and analgesic drugs, but no single drug or combination can prevent or completely relieve symptoms. VZV vaccinations can help to reduce health and economic effects of the virus.
- The Uphill Path to Successful Clinical Trials
Keeping Patients Enrolled
With patient dropout rates sometimes exceeding 30%, managers might improve patient retention by ensuring that the trial's mission is on target, reducing the number of visits and assessments, and simplifying case report forms.
- Business Development Institute
Mobile Health Care Communications Summit
In 2007, there were no medical applications (apps) for mobile devices, but within 3 years, 44 million mobile apps had been downloaded onto electronic devices. This article reviews pingmd and Cancer.Net.
Plus our regular columns: Medication Errors, Prescription: Washington, New Drugs/Drug News/New Medical Devices, Pharmaceutical Approval Update, and Drug Forecast.
Click here to begin reading the current issue.
Click here to subscribe to P&T journal
Call for Papers
P&T is accepting article submissions from its readers. We welcome a wide variety of manuscripts, including drug class reviews, disease state management reviews, pharmacoeconomic analyses, outcomes research evaluations, DUEs, P&T committee experiences, commentaries, book reviews, and letters to the editor. Please contact Sonja Sherritze, via phone (267-685-2779) or mobile 267-907-5642) or e-mail (ssherritze@medimedia.com) for more information.
We hope you enjoy this issue of P&T. If you have any comments or questions about this digital format, please send an e-mail to me at tberberabe@medimedia.com
Tony Berberabe, MPH
Senior Web Editor |
Posts
